Screener
Regencell Bioscience Holdings
RGCRegencell Bioscience Holdings is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Yat-Gai Au, with a market cap of $3.1B.
$3.06B-51.0%
We’re still putting together Regencell Bioscience Holdings’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Regencell Bioscience Holdings up the queue, and we’ll analyze its filings next.
Earnings
Next report
Oct 28, 2026 (in 3 months)Profile
CountryHong Kong
Listed2021
Employees12.0
CEOYat-Gai Au
SectorHealthcare
Websiteregencellbioscience.com
FilingsSEC EDGAR